Mersana Therapeutics, Inc.
NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
Last updated:
Abstract:
Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.
Status:
Application
Type:
Utility
Filling date:
16 Aug 2019
Issue date:
20 Feb 2020